Gut microbiota diversity and mortality in pediatric allo-HSCT; C5 inhibition in atypical HUS; and pembrolizumab plus vorinostat in PD-1-refractory Hodgkin lymphoma's primary photo
  • Blood Podcast Gut microbiota diversity and mortality in pediatric allo-HSCT; C5 inhibition in atypical HUS; and pembrolizumab plus vorinostat in PD-1-refractory Hodgkin lymphoma
  • Podcast Episode | 19 min
Primary photo for Gut microbiota diversity and mortality in pediatric allo-HSCT; C5 inhibition in atypical HUS; and pembrolizumab plus vorinostat in PD-1-refractory Hodgkin lymphoma

Blood Podcast

Gut microbiota diversity and mortality in pediatric allo-HSCT; C5 inhibition in atypical HUS; and pembrolizumab plus vorinostat in PD-1-refractory Hodgkin lymphoma
Podcast Episode | 19 min

Status
Edit Released
Updated Oct 19, 2023

Release date
Oct 19, 2023 (United Kingdom)

Contacts

Become a member to see contact information for Gut microbiota diversity and mortality in pediatric allo-HSCT; C5 inhibition in atypical HUS; and pembrolizumab plus vorinostat in PD-1-refractory Hodgkin lymphoma.

Cast

+ Add Cast
0 cast members

Contribute to this section by adding a cast member

There was an issue loading this tab.
There was an issue loading this tab.
There was an issue loading this tab.
There was an issue loading this tab.
There was an issue loading this tab.
There was an issue loading this tab.
There was an issue loading this tab.
There was an issue loading this tab.

MOVIEmeter

Members only

Become a member to access additional data

Ratings Breakdown